Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Narcolepsy Companies

ID: MRFR/Pharma/4246-HCR
90 Pages
Vikita Thakur
Last Updated: February 16, 2025
Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, sudden and uncontrollable episodes of falling asleep, and disruptions in the sleep-wake cycle. While there are no specific companies dedicated solely to narcolepsy, there are pharmaceutical companies, research institutions, and healthcare organizations that focus on developing treatments, medications, and support services for individuals with narcolepsy.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Narcolepsy Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.85%
2024 Market Size$ 3,418.11 Million
2025 Market Size$ 3,583.89 Million
2035 Market Size$ 5,754.91 Million
Key Players
Jazz Pharmaceuticals
Teva Pharmaceutical Industries
Eisai Co.
Ltd.
Avadel Pharmaceuticals
Moderna
Opportunities
  • Market Growth Projections
  • Growing Awareness and Education
  • Advancements in Treatment Options

Top Industry Leaders in the Narcolepsy Market

Narcolepsy Market
 

Latest Narcolepsy Companies Updates:

Avadel's Xyrem® (sodium oxybate) Avadel received FDA approval for its Xyrem® chewable tablets, offering a new formulation of the existing sodium oxybate medication for cataplexy and excessive daytime sleepiness in narcolepsy patients.

Jazz Pharmaceuticals' Sunosi (solriamfetol) Positive results from a Phase 3 trial in June 2023 demonstrated the efficacy and safety of Sunosi in treating excessive daytime sleepiness associated with narcolepsy.

Takeda's TAK-994, an orexin 2 receptor agonist Phase 2 trial results presented in November 2023 showed promising potential for TAK-994 in improving cataplexy symptoms in narcolepsy patients.

List of Narcolepsy Key companies in the market:

  • Jazz Pharmaceuticals plc (Republic of Ireland)
  • BIOPROJET (Paris)
  • Ligand Pharmaceuticals, Inc. (U.S.)
  • Shire (Republic of Ireland)
  • Arena Pharmaceuticals, Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Shionogi Inc. (U.S.)
  • Graymark Healthcare, Inc. (U.S.)
  • Mylan N.V.  (U.S.)